Bill > HB501

This bill establishes new guidelines for pharmacists when a medical practitioner dies, allowing them to continue dispensing prescriptions up to 180 days after the practitioner's death based on the pharmacist's professional judgment. The bill specifically prohibits dispensing controlled substance prescriptions unless permitted under federal Controlled Substances Act regulations. Additionally, the bill includes a separate provision related to Medicaid services, which restricts the use of Medicaid funds for cross-sex hormones prescribed primarily for gender dysphoria and gender reassignment surgeries that alter physical characteristics typical of a person's biological sex. By creating this new section in Kentucky Revised Statutes (KRS) Chapter 315, the legislation aims to provide clear protocols for pharmacists during challenging circumstances following a practitioner's death while also setting limitations on specific medical treatments covered by Medicaid.

Health and Social Services

https://apps.legislature.ky.gov/record/25RS/hb501.html